P Vennin

458 total citations
23 papers, 359 citations indexed

About

P Vennin is a scholar working on Oncology, Reproductive Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P Vennin has authored 23 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Reproductive Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P Vennin's work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). P Vennin is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). P Vennin collaborates with scholars based in France, Belgium and Luxembourg. P Vennin's co-authors include Jacques Bonneterre, B Hecquet, A Demaille, Jean Djiane, Charles Fournier, Jean-Philippe Peyrat, M M Louchez, Alan G. Harris, Jean Louis Lefèbvre and Catharine Aquino Fournier and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

P Vennin

23 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Vennin France 10 168 114 85 69 61 23 359
Luca Giuseppe Sgrò Italy 11 145 0.9× 77 0.7× 71 0.8× 90 1.3× 105 1.7× 31 447
Theocharis Papageorgiou France 6 128 0.8× 93 0.8× 78 0.9× 70 1.0× 15 0.2× 9 527
Gian Paolo Spinelli Italy 15 190 1.1× 158 1.4× 132 1.6× 22 0.3× 17 0.3× 50 514
Maria Elena Jacomuzzi Italy 9 203 1.2× 38 0.3× 53 0.6× 42 0.6× 63 1.0× 17 360
Yasuhiro Koikawa Japan 11 160 1.0× 217 1.9× 180 2.1× 21 0.3× 28 0.5× 22 483
C. Brumm Germany 7 155 0.9× 32 0.3× 105 1.2× 37 0.5× 98 1.6× 19 332
Paloma Martín-Martorell Spain 11 279 1.7× 190 1.7× 82 1.0× 25 0.4× 26 0.4× 30 426
Melike Özçelik Türkiye 10 95 0.6× 78 0.7× 56 0.7× 27 0.4× 28 0.5× 40 232
Robbin Blau United States 6 403 2.4× 156 1.4× 49 0.6× 28 0.4× 107 1.8× 7 492
Anette Lynge Nielsen Denmark 14 102 0.6× 112 1.0× 100 1.2× 16 0.2× 124 2.0× 24 574

Countries citing papers authored by P Vennin

Since Specialization
Citations

This map shows the geographic impact of P Vennin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Vennin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Vennin more than expected).

Fields of papers citing papers by P Vennin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Vennin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Vennin. The network helps show where P Vennin may publish in the future.

Co-authorship network of co-authors of P Vennin

This figure shows the co-authorship network connecting the top 25 collaborators of P Vennin. A scholar is included among the top collaborators of P Vennin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Vennin. P Vennin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolesnikov-Gauthier, H., Laurence Vanlemmens, Marie‐Christine Baranzelli, et al.. (2010). Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.. Journal of Clinical Oncology. 28(15_suppl). 563–563. 7 indexed citations
2.
Misset, J.L., P Vennin, P. Chollet, et al.. (2001). Multicenter phase II–III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients. Annals of Oncology. 12(10). 1411–1415. 27 indexed citations
3.
Taïeb, S. & P Vennin. (2001). [Evidence-based medicine: towards evidence-based radiology].. PubMed. 82(8). 887–90. 2 indexed citations
4.
Taïeb, S., et al.. (2000). [Predictive value of abdominopelvic scan for optimal surgery of ovarian carcinoma].. PubMed. 29(6). 555–63. 3 indexed citations
5.
Taïeb, S., et al.. (2000). [Predictive value of preoperative abdominopelvic CT for optimal cytoreduction surgery in ovarian carcinoma].. PubMed. 87(3). 265–72. 4 indexed citations
6.
Lhommé, C., P Vennin, Thierry Lesimple, et al.. (1999). A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study. Gynecologic Oncology. 75(2). 187–193. 36 indexed citations
7.
Taïeb, S., et al.. (1998). [Comparative study of tumor evaluation with computerized tomography and surgery in ovarian cancer].. PubMed. 79(1). 27–32. 2 indexed citations
8.
Vilain, M O, A Delobelle-Deroïde, Véronique Cabaret, et al.. (1997). [Immunohistochemical detection of estradiol and progesterone receptors in paraffin sections after treatment with microwaves. Comparison with biochemical assay of receptors in a series of 123 breast cancers with determination of the threshold of optimal positivity].. PubMed. 17(2). 82–8. 4 indexed citations
9.
Tillie‐Leblond, Isabelle, et al.. (1996). [Paraneoplastic superior vena cava thrombosis disclosing an ovarian tumor].. PubMed. 13(6). 598–600. 3 indexed citations
10.
Héron, Jean‐François, C. Lhommé, Pierre Kerbrat, et al.. (1993). High dose chemotherapy in ovarian carcinoma. European Journal of Cancer. 29. S137–S137. 5 indexed citations
11.
Peyrat, J.P., Jacques Bonneterre, P Vennin, et al.. (1990). Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 823–827. 41 indexed citations
12.
Vennin, P, et al.. (1990). Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. European Journal of Cancer and Clinical Oncology. 26(2). 158–158. 1 indexed citations
13.
Vennin, P, Jean-Philippe Peyrat, Jacques Bonneterre, et al.. (1989). Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer.. PubMed. 9(1). 153–5. 45 indexed citations
14.
Fournier, Charles, P Vennin, & B Hecquet. (1988). Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans. Cancer Chemotherapy and Pharmacology. 21(1). 75–7. 22 indexed citations
15.
Hecquet, B, et al.. (1987). Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diamminedichloroplatinum administration in patients with uterine cervical cancer.. PubMed. 47(22). 6134–7. 18 indexed citations
16.
Hecquet, B, P Vennin, Charles Fournier, et al.. (1985). Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. Cancer Chemotherapy and Pharmacology. 15(3). 310–2. 14 indexed citations
17.
Vennin, P, et al.. (1985). [Malignant melanoma in children and adolescents. 8 cases].. PubMed. 14(9). 529–32. 2 indexed citations
18.
Djiane, Jean, et al.. (1984). Stimulation of DNA synthesis by prolactin in human breast tumor explants. Relation to prolactin receptors.. PubMed. 4(4-5). 257–61. 15 indexed citations
19.
Romon, Monique, et al.. (1982). Maladie de Dupuytren et diabète sucré. Annales de Chirurgie de la Main. 1(4). 351–354. 6 indexed citations
20.
Vennin, P, et al.. (1982). [The treatment of acute adrenocortical insufficiency by small dose of hydrocortisone infused by automatic pump (author's transl)].. PubMed. 37(1). 83–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026